Jeannie T. Lee
Direttore/Membro del Consiglio presso GSK PLC
Profilo
Jeannie T.
Lee is the founder of Translate Bio, Inc. (founded in 2011) and Fulcrum Therapeutics, Inc. (founded in 2015).
She is currently the Director at The Genetics Society of America and a Non-Executive Director at GSK Plc (starting in 2024).
Dr. Lee has an undergraduate degree from Harvard University and a doctorate from Perelman School of Medicine.
Posizioni attive di Jeannie T. Lee
| Società | Posizione | Inizio |
|---|---|---|
| GSK PLC | Direttore/Membro del Consiglio | 04/03/2024 |
| The Genetics Society of America | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jeannie T. Lee
| Società | Posizione | Fine |
|---|---|---|
| TRANSLATE BIO, INC. | Fondatore | - |
| FULCRUM THERAPEUTICS, INC. | Fondatore | - |
Formazione di Jeannie T. Lee
| Harvard University | Undergraduate Degree |
| Perelman School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Aziende private | 2 |
|---|---|
| The Genetics Society of America | |
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Jeannie T. Lee
